scholarly journals Allostery in the nitric-oxide dioxygenase mechanism of flavohemoglobin

2020 ◽  
pp. jbc.RA120.016637
Author(s):  
Anne M. Gardner ◽  
Paul R. Gardner

The substrates O2 and NO cooperatively activate the NO dioxygenase function of Escherichia coli flavohemoglobin.  Steady-state and transient kinetic measurements support a structure-based mechanistic model in which O2 and NO movements and conserved amino acids at the E11, G8, E2, E7, B10 and F7 positions within the globin domain control activation.  In the cooperative and allosteric mechanism, O2 migrates to the catalytic heme site via a long hydrophobic tunnel and displaces LeuE11 away from the ferric iron, which forces open a short tunnel to the catalytic site gated by the ValG8/IleE15 pair and LeuE11, which NO permeates and leverages upon to trigger the CD loop to furl, which moves the E and F-helices and switches an electron transfer gate formed by LysF7, GlnE7 and water, which allows FADH2 to reduce the ferric iron, which forms the stable ferric-superoxide-TyrB10/GlnE7 complex, which reacts with internalized NO with a bimolecular rate constant of 1010 M-1 s-1 forming nitrate, which migrates to the CD loop and unfurls the spring-like structure.  To restart the cycle, LeuE11 toggles back to the ferric iron.  Actuating electron transfer with O2 and NO movements averts irreversible NO poisoning and reductive inactivation of the enzyme.  Together, structure snapshots and kinetic constants provide glimpses of intermediate conformational states, time scales for motion, and associated energies.

FEBS Journal ◽  
2006 ◽  
Vol 274 (3) ◽  
pp. 677-686 ◽  
Author(s):  
João B. Vicente ◽  
Francesca M. Scandurra ◽  
João V. Rodrigues ◽  
Maurizio Brunori ◽  
Paolo Sarti ◽  
...  

Biochemistry ◽  
2005 ◽  
Vol 44 (20) ◽  
pp. 7593-7601 ◽  
Author(s):  
Irena Gribovskaja ◽  
Kaleb C. Brownlow ◽  
Sam J. Dennis ◽  
Andrew J. Rosko ◽  
Michael A. Marletta ◽  
...  

2020 ◽  
Vol 9 (5) ◽  
pp. 1255
Author(s):  
Qianhui Wu ◽  
Stacey D. Finley

The endothelial nitric oxide synthase (eNOS) signaling pathway in endothelial cells has multiple physiological significances. It produces nitric oxide (NO), an important vasodilator, and enables a long-term proliferative response, contributing to angiogenesis. This signaling pathway is mediated by vascular endothelial growth factor (VEGF), a pro-angiogenic species that is often targeted to inhibit tumor angiogenesis. However, inhibiting VEGF-mediated eNOS signaling can lead to complications such as hypertension. Therefore, it is important to understand the dynamics of eNOS signaling in the context of angiogenesis inhibitors. Thrombospondin-1 (TSP1) is an important angiogenic inhibitor that, through interaction with its receptor CD47, has been shown to redundantly inhibit eNOS signaling. However, the exact mechanisms of TSP1′s inhibitory effects on this pathway remain unclear. To address this knowledge gap, we established a molecular-detailed mechanistic model to describe VEGF-mediated eNOS signaling, and we used the model to identify the potential intracellular targets of TSP1. In addition, we applied the predictive model to investigate the effects of several approaches to selectively target eNOS signaling in cells experiencing high VEGF levels present in the tumor microenvironment. This work generates insights for pharmacologic targets and therapeutic strategies to inhibit tumor angiogenesis signaling while avoiding potential side effects in normal vasoregulation.


1996 ◽  
Vol 33 (2) ◽  
pp. 76-79 ◽  
Author(s):  
Kazuhiko Iwahashi ◽  
Hirohito Yoneyama ◽  
Taira Ohnishi ◽  
Kazuhiko Nakamura ◽  
Ryosuke Miyatake ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document